Tomonori Yano, Yoshito Hayashi, Ryu Ishihara, Katsunori Iijima, Katsuhiko Iwakiri, Masaya Uesato, Tsuneo Oyama, Chikatoshi Katada, Kenro Kawada, Ryoji Kushima, Yoko Tateishi, Satoshi Fujii, Noriaki Manabe, Hitomi Minami, Hirofumi Kawakubo, Yasuhiro Tsubosa, Sachiko Yamamoto, Tomohiro Kadota, Keiko Minashi, Hiroya Takeuchi, Yuichiro Doki, Manabu Muto
In Japan, standard of care of the patients with resectable esophageal cancer is neoadjuvant chemotherapy (NAC) followed by esophagectomy. Patients unfitted for surgery or with unresectable locally advanced esophageal cancer are generally indicated with definitive chemoradiotherapy (CRT). Local disease control is undoubtful important for the management of patients with esophageal cancer, therefore endoscopic evaluation of local efficacy after non-surgical treatments must be essential. The significant shrink of primary site after NAC has been reported as a good indicator of pathological good response as well as favorable survival outcome after esophagectomy...
February 14, 2024: Esophagus: Official Journal of the Japan Esophageal Society